|
Oramed Pharmaceuticals Inc. (ORMP) DCF Valuation |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Oramed Pharmaceuticals Inc. (ORMP) Bundle
Discover the true potential of Oramed Pharmaceuticals Inc. (ORMP) with our advanced DCF Calculator! Adjust crucial assumptions, explore various scenarios, and evaluate how changes affect the valuation of Oramed Pharmaceuticals Inc. (ORMP) – all within one comprehensive Excel template.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.7 | 2.7 | 2.7 | 2.7 | 1.3 | 1.2 | 1.0 | .9 | .8 | .7 |
| Revenue Growth, % | 0 | 0.25897 | -0.2583 | 0 | -50.43 | -12.61 | -12.61 | -12.61 | -12.61 | -12.61 |
| EBITDA | -14.2 | -11.3 | -25.0 | -37.0 | -15.6 | -1.2 | -1.0 | -.9 | -.8 | -.7 |
| EBITDA, % | -524.34 | -417.42 | -926.34 | -1367.96 | -1162.16 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | .0 | .0 | .1 | 3.6 | .2 | .3 | .2 | .2 | .2 | .2 |
| Depreciation, % | 0.29597 | 0.2583 | 2.85 | 134 | 14.63 | 23.61 | 23.61 | 23.61 | 23.61 | 23.61 |
| EBIT | -14.2 | -11.3 | -25.1 | -40.6 | -15.8 | -1.2 | -1.0 | -.9 | -.8 | -.7 |
| EBIT, % | -524.64 | -417.68 | -929.19 | -1501.96 | -1176.79 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 32.3 | 39.9 | 94.1 | 155.7 | 162.0 | 1.2 | 1.0 | .9 | .8 | .7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payable | 1.3 | .6 | 2.6 | 2.2 | .6 | .7 | .6 | .5 | .5 | .4 |
| Accounts Payable, % | 49.46 | 21.92 | 96.41 | 80.47 | 41.12 | 57.88 | 57.88 | 57.88 | 57.88 | 57.88 |
| Capital Expenditure | .0 | -.1 | -.4 | -.5 | -.3 | -.1 | -.1 | -.1 | -.1 | -.1 |
| Capital Expenditure, % | -0.55494 | -3.03 | -13.87 | -18.35 | -18.96 | -10.95 | -10.95 | -10.95 | -10.95 | -10.95 |
| Tax Rate, % | -8.59 | -8.59 | -8.59 | -8.59 | -8.59 | -8.59 | -8.59 | -8.59 | -8.59 | -8.59 |
| EBITAT | -14.5 | -11.3 | -24.3 | -40.7 | -17.1 | -1.2 | -1.0 | -.9 | -.8 | -.7 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -13.2 | -12.1 | -22.6 | -38.0 | -18.8 | -.9 | -1.0 | -.9 | -.7 | -.6 |
| WACC, % | 9.59 | 9.59 | 9.51 | 9.59 | 9.59 | 9.57 | 9.57 | 9.57 | 9.57 | 9.57 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -3.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -1 | |||||||||
| Terminal Value | -9 | |||||||||
| Present Terminal Value | -6 | |||||||||
| Enterprise Value | -9 | |||||||||
| Net Debt | 43 | |||||||||
| Equity Value | -51 | |||||||||
| Diluted Shares Outstanding, MM | 41 | |||||||||
| Equity Value Per Share | -1.26 |
What You Will Get
- Real ORMP Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Explore various scenarios to assess Oramed's future performance.
- User-Friendly Design: Designed for professionals while remaining approachable for newcomers.
Key Features
- Real-Life ORMP Data: Pre-filled with Oramed Pharmaceuticals' historical financials and future projections.
- Fully Customizable Inputs: Adjust revenue growth, margins, WACC, tax rates, and capital expenditures to fit your analysis.
- Dynamic Valuation Model: Automatic updates to Net Present Value (NPV) and intrinsic value based on your customized inputs.
- Scenario Testing: Create multiple forecast scenarios to evaluate different valuation outcomes for ORMP.
- User-Friendly Design: Intuitive, structured, and suitable for both professionals and beginners.
How It Works
- Download the Template: Gain immediate access to the Excel-based ORMP DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates Oramed Pharmaceuticals’ intrinsic value.
- Test Scenarios: Experiment with different assumptions to assess potential valuation fluctuations.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose Oramed Pharmaceuticals Inc. (ORMP) Calculator?
- Comprehensive Tool: Offers DCF, WACC, and financial ratio analyses tailored for Oramed Pharmaceuticals Inc. (ORMP).
- Customizable Inputs: Modify yellow-highlighted fields to explore different financial scenarios for Oramed Pharmaceuticals Inc. (ORMP).
- Detailed Insights: Automatically computes the intrinsic value and Net Present Value specific to Oramed Pharmaceuticals Inc. (ORMP).
- Preloaded Data: Historical and projected data ensures reliable calculations for Oramed Pharmaceuticals Inc. (ORMP).
- Professional Quality: Perfect for financial analysts, investors, and consultants focusing on Oramed Pharmaceuticals Inc. (ORMP).
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Oramed Pharmaceuticals Inc. (ORMP) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models for Oramed Pharmaceuticals Inc. (ORMP).
- Consultants: Deliver professional valuation insights on Oramed Pharmaceuticals Inc. (ORMP) to clients quickly and accurately.
- Business Owners: Understand how biotech companies like Oramed Pharmaceuticals Inc. (ORMP) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to Oramed Pharmaceuticals Inc. (ORMP).
What the Template Contains
- Historical Data: Includes Oramed Pharmaceuticals Inc.’s (ORMP) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Oramed Pharmaceuticals Inc.’s (ORMP) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Oramed Pharmaceuticals Inc.’s (ORMP) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.